Proficio Capital Partners LLC acquired a new position in Phreesia, Inc. (NYSE:PHR - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 14,995 shares of the company's stock, valued at approximately $377,000.
Several other hedge funds and other institutional investors have also bought and sold shares of PHR. State Street Corp increased its holdings in shares of Phreesia by 7.1% during the third quarter. State Street Corp now owns 1,327,586 shares of the company's stock worth $30,256,000 after purchasing an additional 88,517 shares during the period. Geode Capital Management LLC grew its position in Phreesia by 4.7% during the third quarter. Geode Capital Management LLC now owns 1,245,797 shares of the company's stock worth $28,397,000 after buying an additional 55,934 shares in the last quarter. Charles Schwab Investment Management Inc. increased its stake in Phreesia by 10.3% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 493,448 shares of the company's stock worth $12,415,000 after acquiring an additional 46,209 shares during the period. Barclays PLC raised its holdings in Phreesia by 83.6% in the 3rd quarter. Barclays PLC now owns 94,929 shares of the company's stock valued at $2,163,000 after acquiring an additional 43,225 shares in the last quarter. Finally, Franklin Resources Inc. lifted its position in shares of Phreesia by 3.0% during the 3rd quarter. Franklin Resources Inc. now owns 1,497,631 shares of the company's stock valued at $31,495,000 after acquiring an additional 42,973 shares during the period. Institutional investors and hedge funds own 92.10% of the company's stock.
Analyst Ratings Changes
A number of research analysts recently commented on PHR shares. Citigroup raised their price target on Phreesia from $31.00 to $35.00 and gave the stock a "buy" rating in a research report on Friday, January 10th. Canaccord Genuity Group raised their target price on shares of Phreesia from $34.00 to $35.00 and gave the company a "buy" rating in a report on Thursday, March 13th. KeyCorp boosted their target price on shares of Phreesia from $28.00 to $30.00 and gave the company an "overweight" rating in a research report on Wednesday, January 8th. JMP Securities reissued a "market outperform" rating and issued a $30.00 price objective on shares of Phreesia in a research note on Tuesday, December 10th. Finally, Royal Bank of Canada upgraded Phreesia from a "sector perform" rating to an "outperform" rating and upped their target price for the stock from $24.00 to $32.00 in a research note on Wednesday, January 8th. Twelve investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company currently has an average rating of "Buy" and a consensus price target of $31.33.
View Our Latest Research Report on Phreesia
Insider Activity
In related news, SVP Amy Beth Vanduyn sold 1,311 shares of the firm's stock in a transaction on Monday, January 6th. The stock was sold at an average price of $26.61, for a total transaction of $34,885.71. Following the completion of the transaction, the senior vice president now directly owns 115,633 shares of the company's stock, valued at $3,076,994.13. This trade represents a 1.12 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, General Counsel Allison C. Hoffman sold 3,982 shares of the company's stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $26.61, for a total value of $105,961.02. Following the completion of the sale, the general counsel now owns 159,137 shares in the company, valued at $4,234,635.57. This trade represents a 2.44 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 164,269 shares of company stock valued at $4,661,469 over the last quarter. 5.80% of the stock is owned by company insiders.
Phreesia Price Performance
PHR stock traded down $1.17 during midday trading on Friday, reaching $26.00. 694,034 shares of the stock were exchanged, compared to its average volume of 427,939. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.74 and a quick ratio of 1.74. The stock has a market capitalization of $1.53 billion, a PE ratio of -17.69 and a beta of 1.03. Phreesia, Inc. has a 52 week low of $17.07 and a 52 week high of $30.53. The company has a fifty day moving average price of $27.38 and a 200 day moving average price of $24.18.
About Phreesia
(
Free Report)
Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.
See Also

Before you consider Phreesia, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phreesia wasn't on the list.
While Phreesia currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.